Choose language

Dansk English

We use cookies on accura.dk

accura.dk uses cookies to improve the user-friendliness and functionality. By using our website, you consent to our use of cookies. Read more about cookies at accura.dk. Enjoy.

Read more about our cookie policy and instructions to delete cookies

Print Tip en ven LinkedIn
;

LEO Pharma enters into joint venture with Klox Technologies


Details

Accura has assisted LEO Pharma with entering into an agreement with Klox Technologies to establish a jointly owned company to further develop and commercialise Klox' BioPhotonic technology in dermatology, including the brands Kleresca for acne and Kleresca for skin rejuvenation.

Both companies bring in their contributions from their existing collaboration which started in 2014.

The new joint venture will be an independently managed company that allows for greater strategic expansion of the BioPhotonic technology under the Kleresca brands.

Thomas Weincke, Louise HilligsøeDan Ermose, Anja Staugaard and Sofie Rosenkrantz advised LEO Pharma.


Contact

Thomas Weincke
Thomas Weincke

Partner, Attorney-at-Law

Mobile: +45 3078 6678
thomas.weincke@accura.dk